in heterozygous MODY1 patients [31], activation of signaling pathways [56-61], DNA damage via p53 [62,63], microRNAs [64], diet [35,65,66] and diseases such as colitis and cancer [67,68] could tip the balance between HNF4?? protein and potential binding sites, rendering